Glad that progress has been made reducing the company's exposure to vaccine research. I think that sharp focus should be held on the current drivers eg ADAPT , TAVR and research into the many other areas that our core CardioCel technology can be applied to.
For me, Admedus Vaccines always felt like a hole that the company threw money into ...how long is a piece of string?
“This arrangement will greatly enhance our resources and allow myself, and the team, to accelerate our projects as we delve further into the science that may ultimately lead to the development of groundbreaking vaccines". Professor Ian Frazer.
- Forums
- ASX - By Stock
- Letter of intent to fund Vacs
Glad that progress has been made reducing the company's exposure...
-
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $292.1M |
Open | High | Low | Value | Volume |
$15.35 | $15.35 | $15.00 | $31.00K | 2.035K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 346 | $15.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.24 | 101 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15 | 15.080 |
1 | 232 | 15.070 |
1 | 50 | 15.040 |
1 | 630 | 15.000 |
3 | 1801 | 14.950 |
Price($) | Vol. | No. |
---|---|---|
15.200 | 1 | 1 |
15.250 | 137 | 1 |
15.260 | 36 | 1 |
15.300 | 288 | 1 |
15.340 | 36 | 1 |
Last trade - 11.20am 31/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online